Erysipelothrix rhusiopathiae
Erysipelothrix rhusiopathiae is a Gram-positive, rod-shaped, non-spore-forming bacteria that is the causative agent of Erysipeloid, a skin condition in humans, and Swine erysipelas, a disease in pigs. It is a facultative anaerobe and is catalase-negative.
Taxonomy[edit]
The genus Erysipelothrix is classified within the phylum Firmicutes, class Bacilli, order Lactobacillales, and family Erysipelotrichaceae. The genus contains two species, Erysipelothrix rhusiopathiae and Erysipelothrix tonsillarum, with E. rhusiopathiae being the type species.
Pathogenesis[edit]
Erysipelothrix rhusiopathiae is the causative agent of Erysipeloid, a cutaneous infection in humans, and Swine erysipelas, a systemic disease in pigs. The bacterium is found worldwide and can infect a wide range of animals, including birds, fish, and reptiles. In humans, infection usually occurs through skin wounds that come into contact with contaminated material.
Clinical Manifestations[edit]
In humans, E. rhusiopathiae causes a localized cutaneous infection known as Erysipeloid. Symptoms include redness, swelling, and pain at the site of infection. In rare cases, the bacterium can cause a systemic infection, leading to endocarditis or septicemia.
In pigs, the bacterium causes Swine erysipelas, a disease characterized by skin lesions, fever, and arthritis. The disease can be acute, subacute, or chronic, depending on the virulence of the strain and the immune status of the host.
Diagnosis and Treatment[edit]
Diagnosis of E. rhusiopathiae infection is based on clinical signs and isolation of the bacterium from clinical samples. Treatment involves the use of antibiotics, with penicillin being the drug of choice.
Prevention and Control[edit]
Prevention and control of E. rhusiopathiae infection in animals involve good hygiene practices and vaccination. In humans, prevention involves the use of protective clothing and gloves when handling potentially contaminated material.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

